Stock Events

Stock Events

Shanghai Fudan-Zhangjian Bio-Pharm (1349.HK) Q1 2024 Earnings

25AprExpected

Q1 2023

Q2 2023

Q3 2023

Q1 2024

0

0.33

0.67

1

Details

Expected EPS

0

Actual EPS

0

Surprise EPS

0

Surprise Percent

+NaN%

Description

Shanghai Fudan-Zhangjian Bio-Pharm (1349.HK) will report earnings of for Q1 2024 on April 25, 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.